11,000 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Purchased by Martin Worley Group

Martin Worley Group bought a new stake in Health Catalyst, Inc. (NASDAQ:HCAT) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,000 shares of the company’s stock, valued at approximately $78,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCAT. Portolan Capital Management LLC bought a new position in Health Catalyst during the third quarter valued at $5,402,000. Palogic Value Management L.P. bought a new position in shares of Health Catalyst during the 4th quarter worth $2,262,000. Raymond James Financial Inc. purchased a new stake in Health Catalyst in the 4th quarter worth about $2,044,000. Martin & Co. Inc. TN raised its stake in Health Catalyst by 80.0% in the 4th quarter. Martin & Co. Inc. TN now owns 490,998 shares of the company’s stock valued at $3,471,000 after acquiring an additional 218,293 shares during the period. Finally, Point72 Asset Management L.P. lifted its holdings in Health Catalyst by 69.4% during the third quarter. Point72 Asset Management L.P. now owns 516,934 shares of the company’s stock valued at $4,208,000 after purchasing an additional 211,805 shares during the last quarter. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Citigroup lowered their price target on shares of Health Catalyst from $10.50 to $10.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 target price for the company in a research note on Wednesday, January 8th. Stephens decreased their price target on Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 6th. Stifel Nicolaus cut their price objective on shares of Health Catalyst from $10.00 to $5.00 and set a “hold” rating for the company in a research report on Thursday, February 27th. Finally, Wells Fargo & Company decreased their target price on shares of Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, Health Catalyst presently has an average rating of “Moderate Buy” and an average price target of $9.27.

Insider Buying and Selling at Health Catalyst

In related news, COO Daniel Lesueur sold 5,209 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.51, for a total transaction of $39,119.59. Following the transaction, the chief operating officer now owns 91,253 shares of the company’s stock, valued at approximately $685,310.03. This trade represents a 5.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Linda Llewelyn sold 6,442 shares of Health Catalyst stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $5.80, for a total transaction of $37,363.60. Following the completion of the transaction, the insider now owns 92,260 shares in the company, valued at approximately $535,108. The trade was a 6.53 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 56,530 shares of company stock worth $299,572 over the last ninety days. Insiders own 2.50% of the company’s stock.

Health Catalyst Stock Performance

Shares of NASDAQ HCAT opened at $4.45 on Thursday. The stock’s 50-day moving average is $4.96 and its 200 day moving average is $6.78. The stock has a market cap of $312.44 million, a price-to-earnings ratio of -3.30 and a beta of 1.41. Health Catalyst, Inc. has a 1-year low of $3.76 and a 1-year high of $9.24. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.